Growth in Rx-to-OTC switches

Increased sales opportunities and expiring patents on prescription-only products are two of the drivers behind manufacturers switching from selling their products as prescription or Rx-only to over-the-counter offerings.

Matt Wolf, Contract Pharmacal Corp.’s CEO reports, “Rx-to-OTC switches have fueled tremendous growth in the category, with products such as Ibuprofen, Loratadine, Cetirizine, and Omeprazole. In fact, industry forecasts call for nearly $10 billion in potential switches over the next five years, in branded sales. Science has generated an entire class of products that are safe and effective—and easily purchased without a prescription in any pharmacy.

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
Conveyor setup secrets from top CPG manufacturers
7 proven steps to eliminate downtime and boost packaging line efficiency. Free expert playbook reveals maintenance, sequencing, and handling strategies.
Read More
Conveyor setup secrets from top CPG manufacturers